Chester Li

1.1k total citations
8 papers, 320 citations indexed

About

Chester Li is a scholar working on Epidemiology, Physiology and Genetics. According to data from OpenAlex, Chester Li has authored 8 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 5 papers in Physiology and 4 papers in Genetics. Recurrent topics in Chester Li's work include Lysosomal Storage Disorders Research (5 papers), Virus-based gene therapy research (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). Chester Li is often cited by papers focused on Lysosomal Storage Disorders Research (5 papers), Virus-based gene therapy research (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). Chester Li collaborates with scholars based in United States and Netherlands. Chester Li's co-authors include Seng H. Cheng, Robin J. Ziegler, Maribeth Cherry, Robert J. Desnick, Donna Armentano, Christine M. Barbon, Nelson S. Yew, Scott D. Bercury, James M. Wilson and Scott Lonning and has published in prestigious journals such as Molecular Therapy, Thrombosis and Haemostasis and Human Gene Therapy.

In The Last Decade

Chester Li

7 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chester Li United States 7 161 149 140 103 50 8 320
Maribeth Cherry United States 7 162 1.0× 263 1.8× 208 1.5× 124 1.2× 47 0.9× 7 446
Ayn Schneider United States 6 262 1.6× 187 1.3× 250 1.8× 107 1.0× 32 0.6× 7 459
Kathleen Meyer United States 11 144 0.9× 313 2.1× 219 1.6× 64 0.6× 42 0.8× 23 469
Scott Sproul United States 5 149 0.9× 344 2.3× 227 1.6× 68 0.7× 50 1.0× 17 461
Terri Christianson United States 9 100 0.6× 92 0.6× 39 0.3× 53 0.5× 33 0.7× 11 217
Federico Mingozzi France 6 59 0.4× 232 1.6× 198 1.4× 53 0.5× 10 0.2× 6 352
Barbara Ruben Migeon United States 9 80 0.5× 319 2.1× 198 1.4× 97 0.9× 22 0.4× 11 469
Enyu Ding United States 11 116 0.7× 157 1.1× 175 1.3× 46 0.4× 21 0.4× 11 349
Nathan Gumlaw United States 8 121 0.8× 251 1.7× 124 0.9× 45 0.4× 29 0.6× 9 392
Eric E. Irons United States 9 47 0.3× 170 1.1× 45 0.3× 16 0.2× 24 0.5× 11 247

Countries citing papers authored by Chester Li

Since Specialization
Citations

This map shows the geographic impact of Chester Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chester Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chester Li more than expected).

Fields of papers citing papers by Chester Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chester Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chester Li. The network helps show where Chester Li may publish in the future.

Co-authorship network of co-authors of Chester Li

This figure shows the co-authorship network connecting the top 25 collaborators of Chester Li. A scholar is included among the top collaborators of Chester Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chester Li. Chester Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Ziegler, Robin J., Maribeth Cherry, Christine M. Barbon, et al.. (2006). Correction of the Biochemical and Functional Deficits in Fabry Mice Following AAV8–mediated Hepatic Expression of α-galactosidase A. Molecular Therapy. 15(3). 492–500. 73 indexed citations
2.
Barbon, Christine M., Robin J. Ziegler, Chester Li, et al.. (2005). AAV8-Mediated Hepatic Expression of Acid Sphingomyelinase Corrects the Metabolic Defect in the Visceral Organs of a Mouse Model of Niemann–Pick Disease. Molecular Therapy. 12(3). 431–440. 34 indexed citations
3.
Ziegler, Robin J., Scott Lonning, Donna Armentano, et al.. (2003). AAV2 Vector Harboring a Liver-Restricted Promoter Facilitates Sustained Expression of Therapeutic Levels of α-Galactosidase A and the Induction of Immune Tolerance in Fabry Mice. Molecular Therapy. 9(2). 231–240. 111 indexed citations
4.
Li, Chester, Robin J. Ziegler, Maribeth Cherry, et al.. (2002). Adenovirus-Transduced Lung as a Portal for Delivering α-Galactosidase A into Systemic Circulation for Fabry Disease. Molecular Therapy. 5(6). 745–754. 29 indexed citations
5.
Ziegler, Robin J., Chester Li, Maribeth Cherry, et al.. (2002). Correction of the Nonlinear Dose Response Improves the Viability of Adenoviral Vectors for Gene Therapy of Fabry Disease. Human Gene Therapy. 13(8). 935–945. 38 indexed citations
6.
Li, Chester, Jing‐fei Dong, & José J. López. (2002). The Mucin-like Macroglycopeptide Region of Glycoprotein Ibα is Required for Cell Adhesion to Immobilized von Willebrand Factor (VWF) Under Flow but not for Static VWF Binding. Thrombosis and Haemostasis. 88(10). 673–677. 18 indexed citations
7.
Dong, Jing‐fei, Chester Li, Alicia J. Schade, et al.. (2000). Mutation in the leucine-rich repeat of platelet glycoprotein Ib alpha results in defects in its interaction with immobilized von Willebrand factor under flow.. PubMed. 113(8). 693–8.
8.
Yew, Nelson S., John Marshall, Robin J. Ziegler, et al.. (1999). Increased Duration of Transgene Expression in the Lung with Plasmid DNA Vectors Harboring Adenovirus E4 Open Reading Frame 3. Human Gene Therapy. 10(11). 1833–1843. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026